Cognitive restructuring and improvement of symptoms with cognitive-behavioural therapy and pharmacotherapy in patients with depression

Marian Mihai, Filimon, Filimon Letitia

Informations

• Publié par: biomed
• Publié le: 01 janvier 2010
• Nombre de lectures: 31
• Langue: English

Extrait

Marian and FilimonAnnals of General Psychiatry2010,9(Suppl 1):S173 http://www.annalsgeneralpsychiatry.com/content/9/S1/S173

M E E T I N GA B S T R A C TOpen Access Cognitive restructuring and improvement of symptoms with cognitivebehavioural therapy and pharmacotherapy in patients with depression 1* 2 Mihai Marian, Letitia Filimon st FromCongress on Neurobiology and Clinical Psychopharmacology1 International and European Psychiatric Association Conference on Treatment Guidance Thessaloniki, Greece. 1922 November 2009

Background Since 1960, psychological theories of maladaptive behavior began to change their focus from enviornment to expectation, control, decision and helplessness on the individual level. After 1965, M.E.P. Seligman introduces the concept of learned helplessness representing a giving up reaction determined by the belief that whatever you do it doesn’t matter. According to theory [1] there are at least three types of inferences that people can make and this, changes the way people develop or not hopelessness followed by the simptoms of depressive lack of hope when confronted with negative life events [2]: 1) inference on the motive why certain events occur (inferated cause or causal attri bution); 2) inference on the consequences which might result from events taking place (inferated consequences) and 3) inference on oneself given by events that have happened to oneself at some point (inference of perso nal characteristics). In this study we will investigate the efficiency of cog nitivebehavioural and pharmacotherapeutical interven tions in changing depression symptoms and improving cognitive, emotional disfunctions and perception of social support. We investigate the relation between depression and dis funtional causal attributions, perception of social support, self esteem, emotions and reaction to daily life stress.

Materials and methods Pharmacotherapeutical group (PT). The study included 13 patients diagnosed with depression and at the first

1 The Faculty of Social and Human Sciences, University of Oradea, Oradea, Romania

hospitalization they got disthimia or major depressive episode diagnosis, beeing subsequently treated. Cognitivebehavioural therapy group (CBT) had 12 participants. Control group (C), 13 participants, was selected considering their scores on SCL90, DEP scale. In diagnosis phase, subjects were given to fill in a set of scales similar to psychiatric patients, and it was applied again after 67 weeks and at the end of intervention. A group with high scores on BDI and SCL90, indicating the presence of depression symptoms were tested only in pretest and posttest phases without beeing subjected to any thera peutical intervention. Participant admited into the study formed three groups: pharmacotherapeutical group (PT), psychotherapeutical group (CBT) and control group (C). Psychiatric patients were administrated with anti depressive medication. The psychotherapeutical group followed 1820 sessions of therapy (onehour average ses sion) over a period of 15 weeks; twice a week in the first two and once a week for the remaining. In this study we used the following scales: SCL90; ASQ; SGC; SERV; POMS and SMSSP. Attributional Style Questionnaire (A.S.Q) is an instru ment that measures the“explaning style”patterns repre senting the tendency of selecting certain causal explanations for favorable or unfavorable events. Symptom Check List 90R [3] is an instrument which evaluates the gravity of the symptoms reported by patients. The internal consistency of its subscales is situ ated between .75 and .86 and for ISG it is .97. Testret est trust quotient of the two testing phases (T1 and T2) is between .77 and .87. Multidimensional Scale of Perceived Social Support is an instrument projected to mesure the way people

© 2009 Marian and Filimon; licensee BioMed Central Ltd.